Venus Remedies secures marketing authorisations for key oncology drugs from Morocco
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
The special financing terms offered by United Imaging and structured by Medikabazaar to Krsnaa Diagnostics underscore the strategic importance of this alliance
The inspection concluded with the issuance of a form 483 with five observations
Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
Showcases specialty and sustainable materials for healthcare at Medtec China 2024
Global survey reveals top workforce concerns, evolving strategic priorities, and key technology investment areas for life sciences manufacturers
Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for treatment of schizophrenia
Krsnaa Diagnostics receives LoI from RINPAS for radiology services
Subscribe To Our Newsletter & Stay Updated